SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the "Company"), comments on the new COVID Vaccine policy adopted by the US FDA.The ...

New board‑level committee will steer regulatory strategy, IP development, and product innovation across AIML's AI‑driven health‑tech portfolio TORONTO, ON / ACCESS Newswire / May 22, 2025 / AI/ML ...

LONDON, UNITED KINGDOM / ACCESS Newswire / May 22, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the field of longevity research, focused on ...

Overview of RNA Therapeutics MarketThe Global RNA Therapeutics Market is valued at USD 10.9 Billion in 2024 and is projected ...

Carbon nanotubes are very appealing to researchers to develop novel materials with more favorable features. As a supplier of a wide array of materials, trusted by both industry and academia, Alfa ...

The Global Medical Document Management Market is expected to witness a growth rate of 10-12% in the next five years. The ...

Domino Data Lab, provider of the leading Enterprise AI platform trusted by the largest AI-driven companies, today announced continued life sciences traction and new capabilities to bridge a critical ...

Juvenescence closes $76m first tranche of Series B-1 financing led by Abu Dhabi’s M42 alongside strategic partnership Close of $76m Series B-1 tranche follows recent announcement of groundbreaking ...

The healthcare and laboratory label industry in Western Europe is entering a dynamic phase, with strong momentum forecasted ...

The ophthalmic diagnostic equipment market plays a vital role in modern eye care, supporting the diagnosis and management of various vision-related disorders. These devices enable ophthalmologists and ...

The automated suturing devices market is evolving rapidly as healthcare professionals increasingly seek advanced tools to improve surgical outcomes and reduce operation times. Automated suturing ...

The global market for pharmacovigilance is forecasted to attain USD 9,000.0 million by 2025, expanding at 8.8% CAGR to reach USD 20,902.9 million by 2035. In 2024, the revenue of pharmacovigilance was ...